Bryn Mawr Trust CO Gilead Sciences, Inc. Transaction History

Bryn Mawr Trust CO

$5.48 Billion
Q3 2024

A detailed history of Bryn Mawr Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bryn Mawr Trust CO holds 18,660 shares of GILD stock, worth $1.75 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

18,660

Previous 4,931 278.42%

Holding current value

$1.75 Million

Previous $338,000 362.72%

% of portfolio

0.03%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 25, 2024	BUY	$66.59 - $83.99 $914,214 - $1.15 Million	13,729 Added 278.42%	18,660 $1.56 Million
Q2 2024 Aug 08, 2024	SELL	$63.15 - $72.88 $63,150 - $72,880	-1,000 Reduced 16.86%	4,931 $338,000
Q3 2023 Nov 15, 2023	SELL	$73.94 - $80.67 $65,806 - $71,796	-890 Reduced 13.05%	5,931 $444,000
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $142,138 - $162,129	1,870 Added 37.77%	6,821 $525,000
Q1 2023 May 15, 2023	SELL	$77.31 - $88.08 $77,310 - $88,080	-1,000 Reduced 16.8%	4,951 $411,000
Q2 2022 Aug 11, 2022	SELL	$57.72 - $65.01 $13,160 - $14,822	-228 Reduced 3.69%	5,951 $368,000
Q1 2022 May 16, 2022	SELL	$57.92 - $72.58 $16,970 - $21,265	-293 Reduced 4.53%	6,179 $367,000
Q4 2021 Feb 10, 2022	SELL	$64.88 - $73.64 $147,602 - $167,531	-2,275 Reduced 26.01%	6,472 $470,000
Q3 2021 Oct 26, 2021	BUY	$67.69 - $73.03 $135,109 - $145,767	1,996 Added 29.57%	8,747 $611,000
Q2 2021 Jul 29, 2021	BUY	$63.47 - $69.35 $16,819 - $18,377	265 Added 4.09%	6,751 $465,000
Q1 2021 Apr 23, 2021	SELL	$60.0 - $68.46 $7,020 - $8,009	-117 Reduced 1.77%	6,486 $419,000
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $92,056 - $104,893	-1,625 Reduced 19.75%	6,603 $384,000
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $50,114 - $63,010	-807 Reduced 8.93%	8,228 $520,000
Q1 2020 May 08, 2020	BUY	$62.63 - $80.22 $221,083 - $283,176	3,530 Added 64.12%	9,035 $675,000
Q4 2019 Feb 11, 2020	SELL	$61.62 - $67.78 $51,514 - $56,664	-836 Reduced 13.18%	5,505 $357,000
Q3 2019 Oct 24, 2019	SELL	$62.51 - $69.0 $148,961 - $164,427	-2,383 Reduced 27.32%	6,341 $402,000
Q2 2019 Aug 15, 2019	SELL	$61.87 - $69.38 $6.96 Million - $7.81 Million	-112,532 Reduced 92.81%	8,724 $589,000
Q1 2019 May 15, 2019	BUY	$62.53 - $70.05 $410,259 - $459,598	6,561 Added 5.72%	121,256 $7.88 Million
Q4 2018 Feb 15, 2019	SELL	$60.54 - $79.0 $703,959 - $918,612	-11,628 Reduced 9.2%	114,695 $7.17 Million
Q3 2018 Nov 15, 2018	BUY	$71.28 - $78.92 $106,064 - $117,432	1,488 Added 1.19%	126,323 $9.75 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $217,542 - $253,755	3,353 Added 2.76%	124,835 $8.84 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $110,061 - $134,176	1,511 Added 1.26%	121,482 $9.16 Million
Q4 2017 Feb 15, 2018	SELL	$71.15 - $83.52 $1.7 Million - $1.99 Million	-23,882 Reduced 16.6%	119,971 $8.59 Million
Q3 2017 Aug 28, 2019	SELL	$72.11 - $85.47 $399,489 - $473,503	-5,540 Reduced 3.71%	143,853 $11.7 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $10.8 Million - $12.8 Million	149,393	149,393 $12.1 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bryn Mawr Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Bryn Mawr Trust CO with notifications on news.

Account

Bryn Mawr Trust CO Gilead Sciences, Inc. Transaction History